TrialDiabetes care2012

Sequential intensification of metformin treatment in type 2 diabetes with liraglutide followed by randomized addition of basal insulin prompted by A1C targets.

The primary results report of NCT00856986. Its numbers are set against the trial’s posted results below.

What the trial testedas reported · 988 people · 2012

Not counted

−0.52−0.68 to −0.36

As reported

difference −0.52, 95% CI −0.68 to −0.36

Same as the trial’s posted resultThis paper difference −0.52 (−0.68 to −0.36)Posted, primary outcome difference −0.52 (−0.68 to −0.36)Mean Change From Randomisation in Glycosylated Haemoglobin A1c (HbA1c) at Week 26.

the abstract, start to end

… (estimated treatment difference -0.52 [95% CI -0.68 to -0.36]; P < …

← favours treatmentfavours comparator →

could be chance

Glycemic control

−0.52−0.68 to −0.36

InsulinGlycemic control

1 / 3

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

2024

2025

this paperpooled ittrialcites it